The 3rd International HIV/Viral Hepatitis Co-Infection Meeting provides a unique opportunity for industry, academic, community and governmental stakeholders to interact and develop constructive solutions together that can support equitable access to modern therapeutics while maintaining sustainable innovation. The meeting will provide research-based evidence to demonstrate the value of curative therapies, it will engage policy makers towards creating an environment that supports their wider therapeutic access nationally and internationally, and will focus on identifying opportunities for increased diagnosis and treatment of viral hepatitis in people living with HIV (PLHIV), particularly in low and middle-income settings. 

Organizing Committee

Marina Klein, Canada

Wendy Spearman, South Africa

Monique Andersson, South Africa

Isabelle Andrieux-Meyer, Switzerland

Anchalee Avihingsanon, Thailand

Sanjay Bhagani, UK

Curtis Cooper, Canada

Greg Dore, Australia

Jordan Feld, Canada

Karine Lacombe, France

Gail Matthews, Australia

Sébastien Morin, Switzerland

Marion Peters, USA

Jürgen Rockstroh, Germany

Mark Sulkowski, USA

Tracy Swan, USA


Sunday, 17 July 2016



Durban International Convention Centre (ICC)


Scientific Programme

Download the programme


Registration for the 3rd International HIV/Viral Hepatitis Co-Infection Meeting is open to all AIDS 2016 delegates on a first-come basis.

Click here for more information. 

Educational Programme

Training and educating the next generation of clinicians and researchers is an EACS core activity.

Read more

EACS Treatment Guidelines updated

The EACS Treatment Guidelines 9.0 and the app are available for free on

Apple Store and Google Play Store

Read more 

17th European AIDS Conference

November 6-9, 2019 Basel, Switzerland

Conference website